Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 218 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Completed

Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 (Litifilimab) in Healthy Volunteers and Participants With Systemic Lupus Erythematosus

NCT02106897

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Healthy Volunteers, +4 more
Locations
  • Research Site Anniston, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site Orlando, Florida, United States
  • Research Site Great Neck, New York, United States
View Trial Details
Completed

A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations

NCT02962960

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Research Site Thousand Oaks, California, United States
  • Research Site Orlando, Florida, United States
  • Research Site New York, United States
  • Research Site Charlotte, North Carolina, United States
View all 14 locations
View Trial Details
Completed

An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

NCT03252587

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Local Institution - 0178 Birmingham, Alabama, United States
  • Little Rock Diagnostic Clinic Little Rock, Arkansas, United States
  • Local Institution - 0023 El Cajon, California, United States
  • BioSolutions Clinical Research Center La Mesa, California, United States
View all 192 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

NCT01135459

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Teva Investigational Site 27 Birmingham, Alabama, United States
  • Teva Investigational Site 20 Tucson, Arizona, United States
  • Teva Investigational Site 16 Los Angeles, California, United States
  • Teva Investigational Site 5 Los Angeles, California, United States
View all 86 locations
View Trial Details
Completed

A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)

NCT04305197

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University third hospital Beijing, Beijing Municipality, China
  • Guangdong General Hospital Guangzhou, Guangdong, China
View Trial Details
Completed

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)

NCT03616964

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • University of Arizona Arthritis Center Gilbert, Arizona, United States
  • Arizona Arthritis & Rheumatology Research Phoenix, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates, P. C. Tucson, Arizona, United States
  • Wallace Rheumatic Studies Center Beverly Hills, California, United States
View all 159 locations
View Trial Details

Related conditions